Nyrada (ASX:NYR) Other Current Payables : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nyrada Other Current Payables?

Nyrada's Other Current Payables for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Nyrada's quarterly Other Current Payables increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.22 Mil) but then declined from Jun. 2023 (A$0.22 Mil) to Dec. 2023 (A$0.00 Mil).

Nyrada's annual Other Current Payables increased from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.32 Mil) but then declined from Jun. 2022 (A$0.32 Mil) to Jun. 2023 (A$0.22 Mil).

Nyrada Other Current Payables Historical Data

The historical data trend for Nyrada's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada Other Current Payables Chart

Nyrada Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Other Current Payables

0.49

0.32

0.22

Nyrada Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial			-	0.32	-	0.22	-

Nyrada Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Nyrada Other Current Payables Related Terms

Thank you for viewing the detailed overview of Nyrada's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyrada (ASX:NYR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072

Website

https://www.nyrada.com

Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines